1st Quarter - Report

AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS for AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS

Firm
Client
Income
—
Expenses
$414,161
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act. Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3200 (113th)

Medicare/Medicaid MMM

Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs. Funding to help award recipients defray the cost of data collection requirements. Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed. Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost. Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Insurance INS

Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system. Prompt Payment Initiatives

Contacted: Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Labor Issues/Antitrust/Workplace LBR

H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1493 (113th)

Science/Technology SCI

Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices. Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries. Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product. Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.